Development of a bioreactor-system for pre-endothelialized cardiac patch generation with enhanced viscoelastic properties by combined collagen I compression and stromal cell culture
- Treatment of terminal heart failure still poses a significant clinical problem. Cardiac tissue engineering could offer autologous solutions for the replacement of non-functional myocardial tissue. So far, soft matrix construction and missing large scale prevascularization prevented the application of sizeable cardiac repair patches. We developed a novel bioreactor system for semi-automatic compression of a collagen I hydrogel applying 16 times higher pressure than in previous studies.
- Resistance towards compression stress was investigated for multiple cardiac-related cell types. For scaffold prevascuarization, a tubular cavity was imprinted during the compaction process. Primary cardiac-derived endothelial cells (EC) were isolated from human left atrial appendages (HLAA) and characterized by FACS and immunocytology. EC were then seeded into the preformed channel with dermal fibroblasts as interstitial cell component of the fully cellularized patch.
- After eight days of constant perfusion culture within the same bioreactor, scaffold dynamic modulus and cell viability were analyzed. Endothelial proliferation and vessel maturation were examined by immunohistochemistry and transmission electron microscopy. Our design allowed for scaffold production and dynamic culture in a one-stop-shop model.
- Enhanced compression and cell-mediated matrix remodeling induced a significant increase in scaffold stiffness while ensuring excellent cell survival. For the first time, we could isolate HLAA-derived EC with proliferative potential.
- Endothelial cells within the central channel proliferated during flow culture, continuously expressing endothelial markers (CD31) and displaying basal membrane synthesis (collagen IV, ultrastructural analysis). After seven days of culture, a complete endothelial monolayer could be observed. Covering cells aligned themselves in flow direction and developed mature cell-cell-contacts.
pharmacodane
IGF-1, human |
|||
| RC216-12 | Bio Basic | 1mg | EUR 451.5 |
IGF-1 Protein |
|||
| abx060289-100ug | Abbexa | 100 ug | EUR 493.2 |
IGF-1 Antibody |
|||
| R30443 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: Insulin-like growth factor 1, also known as somatomedin C or mechano growth factor is a protein that in humans is encoded by the IGF1 gene. IGF-1 is a hormone similar in molecular structure to insulin. It plays an important role in childhood growth and continues to have anabolic effects in adults. A synthetic analog of the protein, mecasermin, is used for the treatment of growth failure. IGF-1 consists of 70 amino acids in a single chain with three intramolecular disulfide bridges. |
|||
IGF- 1 Plasmid |
|||
| PVT7112 | Lifescience Market | 2 ug | EUR 319.2 |
IGF- 1 Antibody |
|||
| ABD6096 | Lifescience Market | 100 ug | EUR 525.6 |
rHu IGF-1 (cGMP) |
|||
| AK9901-0000 | Akron Biotech | 1mg | Ask for price |
IGF-1 ELISA Kit |
|||
| DEIA1901 | Creative Diagnostics | 96T | EUR 908.4 |
|
Description: The IGF-1 ELISA is an enzyme immunoassay for the quantitative in vitro diagnostic measurement of Insulin-like Growth Factor 1 (IGF-1) in serum. |
|||
Human IGF-1 LR3 |
|||
| SP-89927-100 | Alpha Diagnostics | 100 ug | EUR 270 |
IGF-1(M23) Antibody |
|||
| BNC470220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), CF647 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC470220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), CF647 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC550220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), CF555 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC550220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), CF555 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC400220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), CF640R conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC400220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), CF640R conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC430220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), CF543 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC430220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), CF543 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC810220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), CF680R conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC810220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), CF680R conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC610220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), CF660R conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC610220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), CF660R conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNUM0220-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against IGF-1(M23), 1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNCB0220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), Biotin conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNCB0220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), Biotin conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNCP0220-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against IGF-1(M23), PerCP conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNCA0220-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against IGF-1(M23), APC conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNCAP0220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNCAP0220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC940220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), CF594 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC940220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), CF594 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNCH0220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNCH0220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNUB0220-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against IGF-1(M23), Concentration: 0.2mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNUB0220-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against IGF-1(M23), Concentration: 0.2mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC040220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), CF405S conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC040220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), CF405S conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC050220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), CF405M conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC050220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), CF405M conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC700220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), CF770 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC700220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), CF770 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC800220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), CF680 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC800220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), CF680 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC680220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), CF568 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC680220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), CF568 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC880220-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(M23), CF488A conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNC880220-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(M23), CF488A conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(M23) Antibody |
|||
| BNCR0220-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against IGF-1(M23), RPE conjugate, Concentration: 0.1mg/mL |
|||
Mouse IGF-1 Antibody |
|||
| 33079-05111 | AssayPro | 150 ug | EUR 313.2 |
IGF-1 Blocking Peptide |
|||
| DF6096-BP | Affbiotech | 1mg | EUR 234 |
IGF-1, human recombinant |
|||
| P1016-.02 | ApexBio | 20 µg | EUR 309.6 |
|
Description: Insulin-like growth factor I (IGF-1) is a polypeptide endocrine hormone structurally similar to insulin and is mainly produced in the liver when stimulated by growth hormone. IGF-1 is a growth factor that stimulates the proliferation of various cell types including muscle, bone, and cartilage tissue |
|||
IGF-1, human recombinant |
|||
| P1016-.1 | ApexBio | 100 µg | EUR 915.6 |
|
Description: Insulin-like growth factor I (IGF-1) is a polypeptide endocrine hormone structurally similar to insulin and is mainly produced in the liver when stimulated by growth hormone. IGF-1 is a growth factor that stimulates the proliferation of various cell types including muscle, bone, and cartilage tissue |
|||
IGF-I (1-3) |
|||
| 5-01367 | CHI Scientific | 4 x 5mg | Ask for price |
IGF-I (1-3) |
|||
| H-2468.0250 | Bachem | 250.0mg | EUR 211.2 |
|
Description: Sum Formula: C12H19N3O6; CAS# [32302-76-4] |
|||
IGF-I (1-3) |
|||
| H-2468.1000 | Bachem | 1.0g | EUR 559.2 |
|
Description: Sum Formula: C12H19N3O6; CAS# [32302-76-4] |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC401020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF640R conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC401020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF640R conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC551020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF555 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC551020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF555 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC431020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF543 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC431020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF543 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC471020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF647 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC471020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF647 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC801020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF680 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC801020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF680 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC811020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF680R conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC811020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF680R conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC611020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF660R conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC611020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF660R conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNUM1020-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against IGF-1(IGF1/1020), 1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNCP1020-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against IGF-1(IGF1/1020), PerCP conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC941020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF594 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC941020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF594 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNCAP1020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNCAP1020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNCA1020-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against IGF-1(IGF1/1020), APC conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNCH1020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNCH1020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNUB1020-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), Concentration: 0.2mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNUB1020-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against IGF-1(IGF1/1020), Concentration: 0.2mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC041020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF405S conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC041020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF405S conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC051020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF405M conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC051020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF405M conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC701020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF770 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC701020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF770 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC881020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF488A conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC881020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF488A conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC681020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF568 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNC681020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), CF568 conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNCB1020-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), Biotin conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNCB1020-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against IGF-1(IGF1/1020), Biotin conjugate, Concentration: 0.1mg/mL |
|||
IGF-1(IGF1/1020) Antibody |
|||
| BNCR1020-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against IGF-1(IGF1/1020), RPE conjugate, Concentration: 0.1mg/mL |
|||
Rat IGF-1 ELISA kit |
|||
| LF-EK50545 | Abfrontier | 1×96T | EUR 777.6 |
IGF-1, DES1-3, human |
|||
| RC216-12B | Bio Basic | 100ug | EUR 203.56 |
Mouse IGF-1 ELISA kit |
|||
| LF-EK50549 | Abfrontier | 1×96T | EUR 777.6 |
IGF-1 (human) ELISA Kit |
|||
| K4775-100 | Biovision | 100 assays | EUR 970.8 |
|
Description: Sensitive, Colorimetric Assay |
|||
IGF-1 ELISA KIT|Human |
|||
| EF000135 | Lifescience Market | 96 Tests | EUR 826.8 |
Human IGF-1 ELISA Kit |
|||
| RK00160 | Abclonal | 96 Tests | EUR 625.2 |
IGF-1, N15 labeled, human |
|||
| RC216-12N | Bio Basic | 5ug | EUR 125.26 |
Antibody for Human IGF-1 |
|||
| SPC-699D-A390 | Stressmarq | 0.1mg | EUR 481.2 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 390. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-A488 | Stressmarq | 0.1mg | EUR 480 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 488. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-A565 | Stressmarq | 0.1mg | EUR 480 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 565. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-APC | Stressmarq | 0.1mg | EUR 478.8 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to APC . |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-DY405 | Stressmarq | 0.1mg | EUR 483.6 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 405. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D | Stressmarq | 0.1mg | EUR 424.8 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is unconjugated. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-A594 | Stressmarq | 0.1mg | EUR 480 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 594. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-A633 | Stressmarq | 0.1mg | EUR 480 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 633. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-A655 | Stressmarq | 0.1mg | EUR 480 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 655. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-A680 | Stressmarq | 0.1mg | EUR 480 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 680. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-A700 | Stressmarq | 0.1mg | EUR 480 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 700. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-ALP | Stressmarq | 0.1mg | EUR 472.8 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Alkaline Phosphatase. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-APCCY7 | Stressmarq | 0.1mg | EUR 565.2 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to APC/Cy7. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-BI | Stressmarq | 0.1mg | EUR 475.2 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Biotin. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-DY350 | Stressmarq | 0.1mg | EUR 496.8 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 350. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-DY488 | Stressmarq | 0.1mg | EUR 471.6 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 488. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-DY594 | Stressmarq | 0.1mg | EUR 474 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 594. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-DY633 | Stressmarq | 0.1mg | EUR 468 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 633. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-FITC | Stressmarq | 0.1mg | EUR 470.4 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to FITC. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-HRP | Stressmarq | 0.1mg | EUR 465.6 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to HRP. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-P594 | Stressmarq | 0.1mg | EUR 488.4 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to PE/ATTO 594. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-PCP | Stressmarq | 0.1mg | EUR 478.8 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to PerCP. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-RPE | Stressmarq | 0.1mg | EUR 476.4 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to RPE . |
|||
Antibody for Human IGF-1 |
|||
| SPC-699D-STR | Stressmarq | 0.1mg | EUR 477.6 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Streptavidin. |
|||
Antibody for Human IGF-1 |
|||
| SPC-699S | Stressmarq | 0.012mg | EUR 78 |
|
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is unconjugated. |
|||
Anti-Rat IGF-1 Antibody |
|||
| 5121-100 | Biovision | each | EUR 379.2 |
Anti-Rat IGF-1 Antibody |
|||
| 5121-30T | Biovision | each | EUR 175.2 |
R³ IGF-1, human recombinant |
|||
| 4216-100 | Biovision | each | EUR 196.8 |
R³ IGF-1, human recombinant |
|||
| 4216-1G | Biovision | each | EUR 48018 |
R³ IGF-1, human recombinant |
|||
| 4216-1MG | Biovision | each | EUR 385.2 |
R³ IGF-1, human recombinant |
|||
| 4216-20MG | Biovision | each | EUR 2461.2 |
R³ IGF-1, human recombinant |
|||
| 4216-50MG | Biovision | each | EUR 4164 |
R³ IGF-1, human recombinant |
|||
| 4216-5MG | Biovision | each | EUR 1011.6 |
IGF-2/ Rat IGF- 2 ELISA Kit |
|||
| ELA-E0051r | Lifescience Market | 96 Tests | EUR 1063.2 |
Plant cell cultures as food-aspects of sustainability and safety
Sustainability and safety aspects of plant cell cultures as food are presented. Applicability of dairy side streams as carbon source and use of natural growth enhancers in cultivation are shown. Biotechnologically produced cellular products are currently emerging to replace and add into the portfolio of agriculturally derived commodities.
Plant cell cultures used for food could supplement current food production. However, still many aspects need to be resolved before this new food concept can enter the market. Issues related to sustainability and safety for human consumption are relevant for both consumers and regulators. In this study, two plant cell cultures, deriving from arctic bramble (Rubus arcticus) and birch (Betula pendula), were cultivated using lactose-rich dairy side streams as alternative carbon sources to replace sucrose.
Biomasses were comparable to those of original plant cell culture media when up to 83% and 75% of the original sucrose was replaced by these side streams for arctic bramble and birch cell cultures, respectively. Furthermore, nutritional composition or sensory properties were not compromised. Synthetic plant growth regulators were replaced by natural components, such as coconut water and IAA for several subculture cycles.
Finally, it was shown that only trace amounts of free growth regulators are present in the cells at the harvesting point and assessment by freshwater crustaceans assay indicated that toxicity of the cells was not exceeding that of traditionally consumed bilberry fruit.
Stability of live attenuated classical swine fever cellculture vaccine virus in liquid form for developing an oral vaccine
Classical swine fever (CSF) is an important viral disease of pigs and controlled by vaccination. Unorganised backyard and wild pigs are difficult to vaccinate by needle vaccination. Here we formulated liquid vaccines using an Indian CSF cell culture vaccine virus and four stabilisers and evaluated their stability at 4 °C, 25 °C and 37 °C up to 24 h for use as oral vaccine.
The stabilisers were Lactalbumin hydrolysate-Trehalose, Lactalbumin hydrolysate-Trehalose-Gelatin, Lactalbumin hydrolysate-Lactose-Sucrose and Lactalbumin hydrolysate-Sucrose. The liquid vaccines, with or without stabilisers, were stable at 4 °C up to 24 h, whereas, a drop of one log10 titre was observed at 25 °C during the same period. At 37 °C, the virus titre diminished by only one log10 with the Lactalbumin hydrolysate-Trehalose (LT) stabiliser up to 24 h compared to two log10 losses in virus titre with other stabilisers and virus control.
We therefore conclude that for developing a CSF oral vaccine, the vaccine virus in liquid form can be used directly during the winter, whereas for developing the oral vaccine for summer, the LT stabiliser would provide maximum stability to the virus to withstand the warm temperature while maintaining adequate therapeutic titre for inducing a protective immune response.
rHu VEGF-121 |
|||
| AK8331-0002 | Akron Biotech | 2µg | Ask for price |
rHu VEGF-121 |
|||
| AK8331-0010 | Akron Biotech | 10µg | Ask for price |
rHu VEGF-121 |
|||
| AK8331-0100 | Akron Biotech | 100µg | Ask for price |
rHu VEGF-121 |
|||
| AK8331-1000 | Akron Biotech | 1mg | Ask for price |
rHu VEGF (cGMP) |
|||
| AK9063-0000 | Akron Biotech | 1mg | Ask for price |
EG VEGF protein |
|||
| 30R-AE013 | Fitzgerald | 20 ug | EUR 327.6 |
|
Description: Purified recombinant Human EG VEGF protein |
|||
EG VEGF antibody |
|||
| 70R-EG002 | Fitzgerald | 50 ug | EUR 327.6 |
|
Description: Affinity purified Goat polyclonal EG VEGF antibody |
|||
EG VEGF antibody |
|||
| 20R-1607 | Fitzgerald | 100 ug | EUR 807.6 |
|
Description: Rabbit polyclonal EG VEGF antibody |
|||
EG-VEGF |
|||
| PR29003 | Neuromics | 5 ug | EUR 277.2 |
Recombinant Mouse EG VEGF Protein, Untagged, E.coli-1mg |
|||
| QP11757-1mg | EnQuireBio | 1mg | EUR 3308.4 |
Recombinant Mouse EG VEGF Protein, Untagged, E.coli-5ug |
|||
| QP11757-5ug | EnQuireBio | 5ug | EUR 186 |
Recombinant Mouse EG VEGF Protein, Untagged, E.coli-20ug |
|||
| QP11757-20ug | EnQuireBio | 20ug | EUR 241.2 |
EG-VEGF Antibody |
|||
| 3489-100 | Biovision | each | EUR 405.6 |
EG-VEGF Antibody |
|||
| 3489R-100 | Biovision | each | EUR 379.2 |
EG-VEGF Antibody |
|||
| 3489R-30T | Biovision | each | EUR 175.2 |
Rat Endocrine gland vascular endothelial growth factor, EG- VEGF |
|||
| ELA-E0024r | Lifescience Market | 96 Tests | EUR 1063.2 |
EG-VEGF, human recombinant |
|||
| 4571-10 | Biovision | each | EUR 183.6 |
EG-VEGF, human recombinant |
|||
| 4571-1000 | Biovision | each | EUR 3583.2 |
EG-VEGF, human recombinant |
|||
| 4571-50 | Biovision | each | EUR 483.6 |
Polyclonal EG-VEGF Antibody |
|||
| APR00114G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EG-VEGF . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal EG-VEGF Antibody |
|||
| APG00002G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human EG-VEGF . This antibody is tested and proven to work in the following applications: |
|||
EG-VEGF Recombinant Protein |
|||
| 40-629 | ProSci | 5 ug | EUR 311.1 |
|
Description: EG-VEGF is a secreted angiogenetic mitogen growth factor expressed in the steroidogenic glands, ovary, testis, adrenal gland, and placenta. EG-VEGF induces proliferation, migration, and fenestration (formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. The human EG-VEGF gene codes for a 105 amino acid polypeptide containing an N-terminal signal sequence of 19 amino acids. Recombinant Human EG-VEGF is a 9.6 kDa protein consisting of 86 amino acid residues, including ten cysteine residues that potentially form five pairs of intra-molecular disulfide bonds. |
|||
EG-VEGF Recombinant Protein |
|||
| 40-702 | ProSci | 5 ug | EUR 311.1 |
|
Description: EG-VEGF is a secreted angiogenetic mitogen growth factor expressed in the steroidogenic glands, ovary, testis, adrenal gland, and placenta. EG-VEGF induces proliferation, migration, and fenestration (formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. The murine EG-VEGF gene codes for a 105 amino acid polypeptide containing an N-terminal signal sequence of 19 amino acids. Recombinant Murine EG-VEGF is a 9.6 kDa protein consisting of 86 amino acid residues, including ten cysteine residues that potentially form five pairs of intra-molecular disulfide bonds. |
|||
EG-VEGF Blocking Peptide |
|||
| 20-abx064278 | Abbexa |
|
|
VEGF-A(VEGF/1063) Antibody |
|||
| BNC401063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF640R conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC401063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF640R conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC551063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF555 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC551063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF555 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC431063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF543 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC431063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF543 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC471063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF647 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC471063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF647 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC801063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF680 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC801063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF680 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC811063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF680R conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC811063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF680R conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC611063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF660R conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC611063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF660R conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNUM1063-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), 1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNCB1063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), Biotin conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNCB1063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), Biotin conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNCP1063-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), PerCP conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC941063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF594 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC941063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF594 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNCAP1063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNCAP1063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNCA1063-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), APC conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNCH1063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNCH1063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNUB1063-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), Concentration: 0.2mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNUB1063-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), Concentration: 0.2mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC041063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF405S conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC041063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF405S conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC051063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF405M conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC051063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF405M conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC701063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF770 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC701063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF770 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC881063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF488A conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC881063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF488A conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC681063-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF568 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC681063-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF568 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNCR1063-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), RPE conjugate, Concentration: 0.1mg/mL |
|||
VEGF/ Rat VEGF ELISA Kit |
|||
| ELA-E0143r | Lifescience Market | 96 Tests | EUR 1063.2 |
VEGF |
|||
| LF-PR009 | Abfrontier | 10 ug | EUR 306 |
|
Description: VEGF protein |
|||
VEGF |
|||
| MO15067 | Neuromics | 500 ug | EUR 1092 |
VEGF |
|||
| PR15028 | Neuromics | 10 ug | EUR 553.2 |
VEGF 121 |
|||
| PR15029 | Neuromics | 5 ug | EUR 498 |
VEGF 162 |
|||
| PR15030 | Neuromics | 25 ug | EUR 553.2 |
VEGF 165 |
|||
| PR15031 | Neuromics | 50 ug | EUR 1477.2 |
VEGF 120 |
|||
| PR15033 | Neuromics | 5 ug | EUR 459.6 |
VEGF 164 |
|||
| PR15034 | Neuromics | 25 ug | EUR 1352.4 |
VEGF 164 |
|||
| PR15035 | Neuromics | 50 ug | EUR 1477.2 |
Prokineticin 1 (EG-VEGF) Antibody |
|||
| 20-abx007755 | Abbexa |
|
|
Mouse EG-VEGF ELISA Kit |
|||
| EME0137 | Abclonal | 96Tests | EUR 625.2 |
Monkey EG-VEGF ELISA Kit |
|||
| EMKE0137 | Abclonal | 96Tests | EUR 625.2 |
Anserini EG-VEGF ELISA Kit |
|||
| EAE0137 | Abclonal | 96Tests | EUR 625.2 |
Porcine EG-VEGF ELISA Kit |
|||
| EPE0137 | Abclonal | 96Tests | EUR 625.2 |
Human EG-VEGF ELISA kit |
|||
| LF-EK50695 | Abfrontier | 1×96T | EUR 777.6 |
Sheep EG-VEGF ELISA Kit |
|||
| ESE0137 | Abclonal | 96Tests | EUR 625.2 |
Rat EG-VEGF ELISA Kit |
|||
| ERE0137 | Abclonal | 96Tests | EUR 625.2 |
Rabbit EG-VEGF ELISA Kit |
|||
| ERTE0137 | Abclonal | 96Tests | EUR 625.2 |
Human EG-VEGF ELISA Kit |
|||
| EHE0137 | Abclonal | 96Tests | EUR 625.2 |
Bovine EG-VEGF ELISA Kit |
|||
| EBE0137 | Abclonal | 96Tests | EUR 625.2 |
Canine EG-VEGF ELISA Kit |
|||
| ECE0137 | Abclonal | 96Tests | EUR 625.2 |
EG-VEGF ELISA KIT|Human |
|||
| EF000094 | Lifescience Market | 96 Tests | EUR 826.8 |
Chicken EG-VEGF ELISA Kit |
|||
| ECKE0137 | Abclonal | 96Tests | EUR 625.2 |
Goat EG-VEGF ELISA Kit |
|||
| EGTE0137 | Abclonal | 96Tests | EUR 625.2 |
EG-VEGF Antibody / Prokineticin 1 |
|||
| R32153 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: Prokineticin-1 is also known as EG-VEGF. The International Radiation Hybrid Mapping Consortium mapped the PROK1 gene to chromosome 1. The protein encoded by this gene induces proliferation, migration, and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. It has little or no effect on a variety of other endothelial and non-endothelial cell types. Its expression is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta), is induced by hypoxia, and often complementary to the expression of vascular endothelial growth factor (VEGF), suggesting that these molecules function in a coordinated manner. |
|||
Eg-Vegf Antibody / Prokineticin-1 |
|||
| R32231 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: Prokineticin-1 is also known as EG-VEGF. The International Radiation Hybrid Mapping Consortium mapped the PROK1 gene to chromosome 1. The protein encoded by this gene induces proliferation, migration, and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. It has little or no effect on a variety of other endothelial and non-endothelial cell types. Its expression is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta), is induced by hypoxia, and often complementary to the expression of vascular endothelial growth factor (VEGF), suggesting that these molecules function in a coordinated manner. |
|||
VEGF-A/ Rat VEGF- A ELISA Kit |
|||
| ELA-E1851r | Lifescience Market | 96 Tests | EUR 1063.2 |
VEGF-B/ Rat VEGF- B ELISA Kit |
|||
| ELA-E0144r | Lifescience Market | 96 Tests | EUR 1063.2 |
VEGF-C/ Rat VEGF- C ELISA Kit |
|||
| ELA-E0145r | Lifescience Market | 96 Tests | EUR 1063.2 |
VEGF-D/ Rat VEGF- D ELISA Kit |
|||
| ELA-E0146r | Lifescience Market | 96 Tests | EUR 1063.2 |
VEGF, CF |
|||
| PR15028CF | Neuromics | 10 ug | EUR 553.2 |
VEGF-C |
|||
| PR27170 | Neuromics | 2 ug | EUR 229.2 |
VEGF-B |
|||
| RA26004 | Neuromics | 100 ul | EUR 646.8 |
VEGF-D |
|||
| RA26005 | Neuromics | 100 ul | EUR 646.8 |
Goat(VEGF) |
|||
| QY-E140039 | Qayee Biotechnology | 96T | EUR 495.6 |
VEGF 121, CF |
|||
| PR15029CF | Neuromics | 5 ug | EUR 498 |
VEGF 162, CF |
|||
| PR15030CF | Neuromics | 25 ug | EUR 553.2 |
VEGF 165, CF |
|||
| PR15031CF | Neuromics | 50 ug | EUR 1477.2 |
VEGF 164, CF |
|||
| PR15034CF | Neuromics | 5 ug | EUR 459.6 |
VEGF 164, CF |
|||
| PR15035CF | Neuromics | 50 ug | EUR 1477.2 |
VEGF-121-Fc |
|||
| E13-m005-1 | EnoGene | 10μg | EUR 411.6 |
VEGF-121-Fc |
|||
| E13-m005-2 | EnoGene | 50μg | EUR 1386 |
VEGF-165-Fc |
|||
| E13-m006-1 | EnoGene | 10μg | EUR 411.6 |
VEGF-165-Fc |
|||
| E13-m006-2 | EnoGene | 50μg | EUR 1386 |
VEGF protein |
|||
| 30R-AV008 | Fitzgerald | 2 ug | EUR 152.4 |
|
Description: Purified recombinant Murine VEGF protein |
|||
VEGF Antibody |
|||
| 5363-100 | Biovision | each | EUR 398.4 |
VEGF Antibody |
|||
| 5363-30T | Biovision | each | EUR 175.2 |
VEGF Antibody |
|||
| 5365-100 | Biovision | each | EUR 379.2 |
VEGF Antibody |
|||
| 5365-30T | Biovision | each | EUR 175.2 |
VEGF antibody |
|||
| 70R-11863 | Fitzgerald | 100 ul | EUR 536.4 |
|
Description: Goat polyclonal VEGF antibody |
|||
VEGF antibody |
|||
| 70R-11864 | Fitzgerald | 100 ug | EUR 483.6 |
|
Description: Rabbit polyclonal VEGF antibody |
|||
VEGF antibody |
|||
| 70R-12327 | Fitzgerald | 100 ug | EUR 483.6 |
|
Description: Rabbit polyclonal VEGF antibody |
|||
VEGF antibody |
|||
| 70R-12328 | Fitzgerald | 100 ug | EUR 483.6 |
|
Description: Rabbit polyclonal VEGF antibody |
|||
VEGF antibody |
|||
| 70R-12329 | Fitzgerald | 100 ug | EUR 483.6 |
|
Description: Rabbit polyclonal VEGF antibody |
|||
VEGF antibody |
|||
| 70R-13764 | Fitzgerald | 100 ug | EUR 418.8 |
|
Description: Affinity purified Rabbit polyclonal VEGF antibody |
|||
VEGF antibody |
|||
| 70-VR20 | Fitzgerald | 50 ug | EUR 392.4 |
|
Description: Affinity purified Rabbit polyclonal VEGF antibody |
|||
VEGF Antibody |
|||
| 48707-100ul | SAB | 100ul | EUR 399.6 |
VEGF Antibody |
|||
| 48707-50ul | SAB | 50ul | EUR 286.8 |
VEGF antibody |
|||
| 10-2585 | Fitzgerald | 250 ug | EUR 590.4 |
|
Description: Mouse monoclonal VEGF antibody |
|||
VEGF antibody |
|||
| 10-2586 | Fitzgerald | 100 ug | EUR 289.2 |
|
Description: Mouse monoclonal VEGF antibody |
|||
VEGF antibody |
|||
| 10R-V101ax | Fitzgerald | 100 ug | EUR 571.2 |
|
Description: Mouse monoclonal VEGF antibody |
|||
VEGF antibody |
|||
| 10R-V101b | Fitzgerald | 200 ug | EUR 805.2 |
|
Description: Mouse monoclonal VEGF antibody |
|||
VEGF antibody |
|||
| 10R-V109A | Fitzgerald | 500 ug | EUR 327.6 |
|
Description: Mouse monoclonal VEGF antibody |
|||
VEGF antibody |
|||
| 10R-7735 | Fitzgerald | 500 ug | EUR 678 |
|
Description: Mouse monoclonal VEGF antibody |
|||
VEGF antibody |
|||
| 70R-VG001 | Fitzgerald | 100 ug | EUR 392.4 |
|
Description: Affinity purified Goat polyclonal VEGF antibody |
|||
VEGF antibody |
|||
| 70R-VR001x | Fitzgerald | 50 ug | EUR 392.4 |
|
Description: Affinity purified Rabbit polyclonal VEGF antibody |
|||
VEGF antibody |
|||
| 70R-VR003 | Fitzgerald | 50 ug | EUR 327.6 |
|
Description: Affinity purified Rabbit polyclonal VEGF antibody |
|||
VEGF antibody |
|||
| 70R-VR004 | Fitzgerald | 50 ug | EUR 327.6 |
|
Description: Affinity purified Rabbit polyclonal VEGF antibody |
|||
VEGF antibody |
|||
| 70R-VR006 | Fitzgerald | 50 ug | EUR 327.6 |
|
Description: Affinity purified Rabbit polyclonal VEGF antibody |
|||
VEGF Antibody |
|||
| ABF5131 | Lifescience Market | 100 ug | EUR 525.6 |
VEGF antibody |
|||
| PAab09933 | Lifescience Market | 100 ug | EUR 463.2 |
VEGF Antibody |
|||
| R31500 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: VEGF is the only mitogen that specifically acts on endothelial cells. It may be a major regulator of tumor angiogenesis in vivo. It is structurally related to platelet-derived growth factor. VEGF shares homology with the PDGF A chain and B chain, including conservation of all 8 cysteines found in PDGFA and PDGFB. VEGF gene contains 8 exons. VEGF induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. And this gene also can regulate haematopoietic stem cell survival by an internal autocrine loop mechanism. What’s more, it also stimulates neurogenesis in vitro and in vivo. |
|||
VEGF Antibody |
|||
| V8154-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: This mAb recognizes proteins of 19-22kDa (reducing) and 38kDa-44kDa (non-reducing), identified as various isoforms of Vascular Endothelial Growth Factor or Vascular Permeability Factor (VEGF/VPF). It is highly specific to VEGF, which is a homodimeric, disulfide-linked glycoprotein with a close homology to platelet-derived growth factor (PDGF). There are multiple isoforms of VEGF containing 206-, 189-, 165-, and 121-amino acid residues. The smaller two isoforms, VEGF165 and VEGF121, are secreted proteins and act as diffusible agents, whereas the larger two remain cell associated. VEGF/VPF plays an important role in angiogenesis, which promotes tumor progression and metastasis. |
|||
VEGF Antibody |
|||
| V8154-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: This mAb recognizes proteins of 19-22kDa (reducing) and 38kDa-44kDa (non-reducing), identified as various isoforms of Vascular Endothelial Growth Factor or Vascular Permeability Factor (VEGF/VPF). It is highly specific to VEGF, which is a homodimeric, disulfide-linked glycoprotein with a close homology to platelet-derived growth factor (PDGF). There are multiple isoforms of VEGF containing 206-, 189-, 165-, and 121-amino acid residues. The smaller two isoforms, VEGF165 and VEGF121, are secreted proteins and act as diffusible agents, whereas the larger two remain cell associated. VEGF/VPF plays an important role in angiogenesis, which promotes tumor progression and metastasis. |
|||
VEGF Antibody |
|||
| V8154SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: This mAb recognizes proteins of 19-22kDa (reducing) and 38kDa-44kDa (non-reducing), identified as various isoforms of Vascular Endothelial Growth Factor or Vascular Permeability Factor (VEGF/VPF). It is highly specific to VEGF, which is a homodimeric, disulfide-linked glycoprotein with a close homology to platelet-derived growth factor (PDGF). There are multiple isoforms of VEGF containing 206-, 189-, 165-, and 121-amino acid residues. The smaller two isoforms, VEGF165 and VEGF121, are secreted proteins and act as diffusible agents, whereas the larger two remain cell associated. VEGF/VPF plays an important role in angiogenesis, which promotes tumor progression and metastasis. |
|||
Human EG-VEGF ELISA kit (4X96T) |
|||
| LF-EK50696 | Abfrontier | 4×96T | EUR 2641.2 |
Human EG-VEGF PicoKine ELISA Kit |
|||
| EK0575 | BosterBio | 96 wells | EUR 547.2 |
|
Description: For quantitative detection of human EG-VEGF in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
|||
ELISA kit for Human EG-VEGF |
|||
| EK5247 | SAB | 96 tests | EUR 663.6 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human EG-VEGF in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Guinea Pig EG-VEGF ELISA Kit |
|||
| EGE0137 | Abclonal | 96Tests | EUR 625.2 |
EG-VEGF ELISA Kit (Human) (OKBB00283) |
|||
| OKBB00283 | Aviva Systems Biology | 96 Tests | EUR 652.8 |
|
Description: Description of target: EG-VEGF, Endocrine glandderived vascular endothelial growth factor, is a human protein encoded by by the PROKR1 gene. Its gene is mapped to chromosome 1. The 1.4-kb cDNA encodes a protein of 105 amino acids with a well defined signal sequence. The mature protein is predicted to have 86 amino acids. Northern blot analysis demonstrated expression in testis, ovary, adrenal gland, and placenta. EG-VEGF has played a vital role in inducing proliferation, migration, and fenestration in capillary endothelial cells derived from endocrine glands.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 7 pg/mL |
|||
Anti-VEGF Antibody Clone VEGF/1063, Unconjugated-100ug |
|||
| 7422-MSM1-P1 | EnQuireBio | 100ug | EUR 513.6 |
Rat VEGF-A |
|||
| 91008 | BPS Bioscience | 10 µg | EUR 220 |
|
Description: Recombinant rat vascular endothelial growth factor A (VEGF-A) expressed in E. coli cells. Rat recombinant VEGF-A contains 165 amino acids and has a molecular weight of 38.7 kDa. VEGF is an important growth factor involved in both vasculogenesis and angiogenesis. |
|||
VEGF Mouse mAb |
|||
| A17877-100ul | Abclonal | 100 ul | EUR 460.8 |
VEGF Mouse mAb |
|||
| A17877-200ul | Abclonal | 200 ul | EUR 664.8 |
VEGF Mouse mAb |
|||
| A17877-20ul | Abclonal | 20 ul | EUR 265.2 |
VEGF Mouse mAb |
|||
| A17877-50ul | Abclonal | 50 ul | EUR 318 |
VEGF Rabbit pAb |
|||
| A12303-100ul | Abclonal | 100 ul | EUR 369.6 |
VEGF Rabbit pAb |
|||
| A12303-200ul | Abclonal | 200 ul | EUR 550.8 |
VEGF Rabbit pAb |
|||
| A12303-20ul | Abclonal | 20 ul | EUR 219.6 |
VEGF Rabbit pAb |
|||
| A12303-50ul | Abclonal | 50 ul | EUR 267.6 |
VEGF B protein |
|||
| 30R-AV018 | Fitzgerald | 20 ug | EUR 327.6 |
|
Description: Purified recombinant Human VEGF B protein |
|||
VEGF C protein |
|||
| 30R-AV019 | Fitzgerald | 20 ug | EUR 327.6 |
|
Description: Purified recombinant Human VEGF C protein |
|||
VEGF D protein |
|||
| 30R-AV020 | Fitzgerald | 10 ug | EUR 327.6 |
|
Description: Purified recombinant Human VEGF D protein |
|||
VEGF C antibody |
|||
| 20R-1831 | Fitzgerald | 100 ug | EUR 807.6 |
|
Description: Goat polyclonal VEGF C antibody |
|||
Human VEGF 121 Antibody |
|||
| 32562-05111 | AssayPro | 150 ug | EUR 313.2 |
Human VEGF 165 Antibody |
|||
| 32563-05111 | AssayPro | 150 ug | EUR 313.2 |
VEGF-C Antibody |
|||
| 5633-100 | Biovision | each | EUR 444 |
VEGF-C Antibody |
|||
| 5633R-100 | Biovision | each | EUR 379.2 |
VEGF-C Antibody |
|||
| 5633R-30T | Biovision | each | EUR 175.2 |
VEGF-C Antibody |
|||
| 5634-100 | Biovision | each | EUR 379.2 |
VEGF-C Antibody |
|||
| 5634-30T | Biovision | each | EUR 175.2 |
VEGF-B Antibody |
|||
| 5641-100 | Biovision | each | EUR 379.2 |
VEGF-B Antibody |
|||
| 5641-30T | Biovision | each | EUR 175.2 |
VEGF-D Antibody |
|||
| 5643-100 | Biovision | each | EUR 379.2 |
VEGF-D Antibody |
|||
| 5643-30T | Biovision | each | EUR 175.2 |
VEGF-A Antibody |
|||
| F41972-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
|
Description: This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms. |
|||